Punitive Damage Trial in Prempro Suit to Proceed After Appeal Rejected

The U.S. Supreme Court has rejected an appeal by Pfizer that sought to overturn a $2.7 million award for damages in a 2008 Prempro breast cancer lawsuit

The complaint was brought by Donna Scroggin, who established at an earlier trial that side effects of the hormone replacement therapy Prempro caused her to develop breast cancer. She was awarded $2.7 million in compensatory damages and $27 million in punitive damages against Wyeth and Upjohn, which are now both owned by Pfizer. Late last year, the U.S. Court of Appeals in St. Louis overturned the punitive damages award and called for a new trial, but left the $2.7 million compensatory award in place.

In a short order issued this week, the Supreme Court rejected Pfizer’s further appeal of that decision, meaning that a new punitive damage Prempro trial will move forward. The jury will not reconsider the liability or compensatory damage award, but will only decide whether punitive damages should be awarded as a result of the drug makers failure to conduct adequate studies and warn about the risk of breast cancer from Prempro.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Prempro is a hormone replacement therapy (HRT) that contains a combination of the drugs Provera and Premarin. The drug was originally developed by Wyeth, which was acquired by Pfizer last year. HRTs use hormones and progestins to artificially boost hormone levels in women undergoing menopause due to surgery or in postmenopausal women, to provide relief from symptoms such as hot flashes, irregular menstruation or weight gain.

In Scroggin’s case, the 8th U.S. Circuit Court of Appeals upheld the compensatory damages award and agreed that there was sufficient evidence presented at trial to warrant submitting the question of punitive damages to the jury. However, as a result of procedural problems with some of the evidence presented during the punitive damages phase, the appeals court ordered that the $27 million punitive damage portion of the award must be tossed, and ordered a new trial to determine whether such damages are warranted and the amount.

Scroggin’s Prempro suit is one of about 9,000 pending against Pfizer’s Wyeth unit by women who claim that they developed breast cancer from the hormone replacement therapy. The cases allege that the drug maker intentionally hid the risk of breast cancer from women. Wyeth has lost five of the last six HRT lawsuits that have gone to trial, resulting in tens of millions of dollars in compensatory and punitive damages. The punitive damages have been awarded by juries who saw Wyeth’s behavior as reckless disregard for the risk of injury to consumers.

1 Comments

  • CathyJuly 29, 2010 at 9:30 pm

    I took Prempro for a number of years and was diagnosed with breast cancer in Fall 2008. I had a lumpectomy and afterwards radiation for 6 weeks.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted today)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.